Variables | MPO-positive (n = 316) | PR3-positive (n = 33) | p-value |
Age (years) Gender (M/F) Variants of AAV MPA GPA EGPA General manifestation Skin involvement ENT involvement Cardiovascular involvement Abdominal involvement Nervous system involvement Pulmonary involvement Alveolar hemorrhage Interstitial lung disease Kidney involvement Proteinuria and/or Hematuria SCR (μmol/L) Hemoglobin (g/L) Serum albumin (g/L) Complement C3 (g/L) Complement C4 (g/L) BVAS Survival Death | 64.4 ± 12.2 148/168
238 (75.3%) 63 (19.9%) 15 (4.8%) 220 (69.6%) 17 (5.4%) 14 (4.4%) 105 (33.2%) 90 (28.5%) 37 (11.7%) 154 (48.7%) 44 (13.9%) 99 (31.3%) 262 (82.9%) 237 (75.0%) 239 (80.5, 602.5) 90.5 (75.0, 108.0) 30.0 (26.0, 35.0) 0.79 (0.66,0.93) 0.22 (0.17,0.27) 15.0 (11.0,18.0) 168 (57.5%) 124 (42.5%) | 56.4 ± 15.4 17/16
20 (60.6%) 11 (33.3%) 2 (6.1%) 22 (66.7%) 5 (15.2%) 1 (3.0%) 7 (21.2%) 10 (30.3%) 2 (6.1%) 10 (30.3%) 4 (12.1%) 3 (9.1%) 25 (75.8%) 21 (63.6%) 145 (68.0, 474.5) 97.0 (84.0, 120.5) 31.0 (25.0, 36.0) 0.80 (0.62, 1.00) 0.23 (0.19, 0.29) 15.0 (9.0, 17.5) 17 (54.8%) 14 (45.2%) | 0.007 0.608
0.173
0.726 0.069 1.000 0.159 0.826 0.490 0.044 0.984 0.008 0.306 0.157 0.153 0.134 0.895 0.883 0.368 0.663 0.773
|